AMEGA Biotech is a biotechnology organization with a new vision on the production and commercialization of human biopharmaceuticals aimed at achieving the highest quality standards.
With a focus on competitiveness and time-to-market, the structure of AMEGA Biotech allows control of all the manufacturing processes, from the Active Pharmaceutical Ingredient (API) to the Finished Dosage Form.
This new vision enables AMEGA Biotech to access markets such as Latin America, MENA, Turkey, Southeast Asia, Russia, Ukraine.
The AMEGA biotech project adheres to a set of core values that guide our actions as a company and our relationships with employees, partners, customers and the community.
We are committed to the highest levels of scientic excellence through continuous investment in advanced scientic technologies and professional training, creating networks that encourage new insights and ideas.
Innovation drives all our activities, from development to production and business development actions. We have an attitude towards the novel and the better behind every stage of the process.
We believe that successful results depend on team feedback and mutual enrichment. We promote collaboration at all levels as a platform for ensuring patients, partners, staff and shareholders an inclusive and thorough outcome.
We hold ourselves to the highest of ethical principles in all aspects of our business. We carry out our work focusing on quality and showing a high degree of transparency in our dealings with competitors, customers, partners and institutions.
From individual behavior to corporate actions, we base our performance in mutual trust and responsibility. We act as we think and we reflect what we believe.
We share and profess the capacity to adapt to changing business and regulatory environments, both locally and internationally. Flexibility is also reflected in the continuous expansion of manufacturing capacities.
Quality Assurance is based on a system of standardized procedures to which every employee adheres to. We are focused on developing and exercising a quality policy with established quality objectives that are permanently reviewed.
We are aware of the impact that any human action, whether as individuals or as a company, has on the wellbeing of communities and we commit ourselves to the economical, social and environmental development of the areas affected by our activities.
Our organization has set precedent for a dynamic development model that is able to control all the processes in the biopharmaceutical production chain as well as quality assurance, from the Active Pharmaceutical Ingredient (API) to the Finished Dosage Form (FDF).
AMEGA Biotech combines the best-qualied professionals and scientists in the field and designs skillful and creative working teams that share our vision and values. This highly qualied resource is the key engine in our contribution to biotechnology and in our pursuit of improving people’s quality of life.
Our team includes experienced scientists, many of which are bearing PhD degrees. Their solid trajectory certies the expertise in a broad range of cell cultures such as CHO, E-coli, BHK and yeast cells.